<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical manifestations and diagnosis of chronic paracoccidioidomycosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical manifestations and diagnosis of chronic paracoccidioidomycosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical manifestations and diagnosis of chronic paracoccidioidomycosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marcio Nucci, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Arnaldo L Colombo, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carol A Kauffman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Milana Bogorodskaya, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 17, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Paracoccidioidomycosis is a systemic endemic mycotic disease caused by the thermally dimorphic fungi of the genus
         <em>
          Paracoccidioides
         </em>
         ,
         <em>
         </em>
         encompassing
         <em>
          Paracoccidioides brasiliensis
         </em>
         complex and
         <em>
          Paracoccidioides lutzii
         </em>
         . The fungus has a geographic distribution limited to Mexico and Central and South America, where paracoccidioidomycosis is mostly diagnosed in male rural workers. However, an increasing number of cases have been documented in patients from non-endemic areas who acquired the disease during visits to Latin American countries [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The clinical manifestations and diagnosis of chronic paracoccidioidomycosis will be reviewed here. The clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis as well as the mycology, epidemiology, and treatment of paracoccidioidomycosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2438.html" rel="external">
          "Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2434.html" rel="external">
          "Mycology and epidemiology of paracoccidioidomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2422.html" rel="external">
          "Treatment of paracoccidioidomycosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following inhalation,
         <em>
          Paracoccidioides
         </em>
         spp typically cause asymptomatic pulmonary infection. If the infection is not contained by the host, the disease may evolve into one of two patterns: (1) the chronic form, which represents reactivation of the primary infection, has an insidious evolution, and is the most common clinical form, or (2) the acute/subacute form, with limited host response and fast dissemination to the reticuloendothelial system [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2438.html" rel="external">
          "Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis"
         </a>
         .)
        </p>
        <p>
         Over 80 to 90 percent of cases of paracoccidioidomycosis are the chronic form, which may present months or years following the primary infection [
         <a href="#rid3">
          3
         </a>
         ]. It most commonly affects men who work in agriculture, and are between 30 and 60 years of age [
         <a href="#rid4">
          4
         </a>
         ]. In one study that described the clinical manifestations of 34 cases of paracoccidioidomycosis caused by
         <em>
          P
         </em>
         .
         <em>
          lutzii
         </em>
         , all patients presented with the chronic form and had clinical characteristics similar to those described in cases caused by
         <em>
          P. brasiliensis
         </em>
         [
         <a href="#rid5">
          5
         </a>
         ] (See
         <a class="medical medical_review" href="/z/d/html/2434.html" rel="external">
          "Mycology and epidemiology of paracoccidioidomycosis", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p>
         <em>
          Paracoccidioides
         </em>
         spp can disseminate to any part of the body by the hematogenous or lymphatic routes. Thus, as with other systemic endemic fungal infections, any organ can be affected. Signs and symptoms usually progress slowly, and may be related to a single organ or to several organs. (See
         <a class="medical medical_review" href="/z/d/html/2434.html" rel="external">
          "Mycology and epidemiology of paracoccidioidomycosis", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Signs and symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         The chronic form of the disease usually presents as pulmonary infiltrates and upper respiratory mucosal lesions [
         <a href="#rid6">
          6
         </a>
         ]. Unifocal disease occurs in only 25 percent of cases and is most commonly described in the lungs [
         <a href="#rid3">
          3
         </a>
         ]. Disease can be severe, and in one study that evaluated 6732 hospitalizations due to paracoccidioidomycosis, the overall in-hospital mortality was 5 percent [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Lungs
         </span>
         <span class="headingEndMark">
          —
         </span>
         The lungs are frequently involved in chronic paracoccidioidomycosis, either alone or with other organs. In a review of 352 patients with paracoccidioidomycosis, 77 percent had lung involvement [
         <a href="#rid3">
          3
         </a>
         ]. Dry cough and dyspnea are the most frequent presenting symptoms, but sputum production may be observed [
         <a href="#rid8">
          8
         </a>
         ]. Hemoptysis may occur in some patients [
         <a href="#rid9">
          9
         </a>
         ]. However, it is common for patients to present with extensive lung involvement (including fibrosis) with few or no symptoms of pulmonary disease [
         <a href="#rid10">
          10,11
         </a>
         ]. This is important because there is an increased risk of progressive pulmonary fibrosis among patients with more extensive radiologic findings at the initial presentation [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="local">
          'Sequelae'
         </a>
         below and
         <a class="local">
          'Radiographic findings'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Mucosa
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mucosal involvement occurs in over 50 percent of cases. The mouth (oropharynx, lips, tongue, gingiva, palate) is most frequently affected, followed by the larynx [
         <a href="#rid12">
          12-15
         </a>
         ]. The typical lesion is a painful ulcer with ragged borders and small spots of hemorrhage (
         <a class="graphic graphic_picture graphicRef69875" href="/z/d/graphic/69875.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef62412" href="/z/d/graphic/62412.html" rel="external">
          picture 2
         </a>
         ). Patients complain of soreness, sialorrhea, hoarseness, odynophagia, and/or dysphagia.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Other sites
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other sites that can be involved in patients with chronic paracoccidioidomycosis include the skin [
         <a href="#rid16">
          16
         </a>
         ], lymph nodes [
         <a href="#rid17">
          17
         </a>
         ], adrenal glands [
         <a href="#rid18">
          18
         </a>
         ], and central nervous system (CNS) (
         <a class="graphic graphic_picture graphicRef62412" href="/z/d/graphic/62412.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid19">
          19
         </a>
         ]. Adrenal lesions are very common in patients with disseminated disease; this involvement is manifested by asymptomatic limited adrenal reserve in 15 to 40 percent and, less commonly, by Addison's disease in approximately 3 percent [
         <a href="#rid18">
          18,20
         </a>
         ]. CNS involvement has been reported in 10 to 15 percent of patients and presents with clinical manifestations associated with space-occupying lesions such as seizures and focal neurologic signs [
         <a href="#rid21">
          21,22
         </a>
         ]. Less frequently involved organs include bones [
         <a href="#rid23">
          23,24
         </a>
         ], joints [
         <a href="#rid23">
          23
         </a>
         ], genital organs [
         <a href="#rid25">
          25
         </a>
         ] and eyes [
         <a href="#rid26">
          26,27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Radiographic findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lung imaging (chest radiograph or computed tomography [CT]) typically reveals mixed interstitial and alveolar infiltrates, which are usually perihilar, bilateral, and symmetrical with predominantly lower lung field involvement (
         <a class="graphic graphic_diagnosticimage graphicRef63969" href="/z/d/graphic/63969.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid3">
          3,9,11,28
         </a>
         ]. The most frequent images on chest CT are ground-glass attenuations, consolidations, nodules, masses, cavities, and septal or interlobular thickening; the reversed halo sign may be present [
         <a href="#rid2">
          2,29
         </a>
         ]. Long-standing pulmonary involvement may lead to serious sequelae such as fibrosis, bullae, and emphysema (
         <a class="graphic graphic_diagnosticimage graphicRef74974" href="/z/d/graphic/74974.html" rel="external">
          image 2
         </a>
         ) [
         <a href="#rid6">
          6,11
         </a>
         ].
        </p>
        <p>
         CNS radiographic findings typically include ring-enhancing lesions located in the cerebrum, thalamus, cerebellum, brainstem, and/or spinal cord (
         <a class="graphic graphic_diagnosticimage graphicRef63969" href="/z/d/graphic/63969.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid19">
          19
         </a>
         ], frequently with perilesional edema. Meningeal involvement and hydrocephalus may also be present [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         Joint involvement is characterized by effusion, periarticular bony erosions, and/or narrowing of the joint space, whereas the typical radiographic finding of bone involvement is bone lysis with or without a rim of sclerosis [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         Other radiographic findings depend upon which organs are affected [
         <a href="#rid31">
          31
         </a>
         ] (See
         <a class="local">
          'Signs and symptoms'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Sequelae
         </span>
         <span class="headingEndMark">
          —
         </span>
         An important aspect of chronic paracoccidioidomycosis is the development of sequelae, mostly represented by chronic respiratory failure that results from fibrosis (
         <a class="graphic graphic_diagnosticimage graphicRef74974" href="/z/d/graphic/74974.html" rel="external">
          image 2
         </a>
         ), and limited adrenal reserve or Addison's disease [
         <a href="#rid6">
          6,11
         </a>
         ]. Other sequelae include emphysema, formation of bullae, and pulmonary arterial hypertension [
         <a href="#rid6">
          6,11
         </a>
         ]. Microstomia and stenosis of the glottis and/or trachea with associated dysphonia can also occur (
         <a class="graphic graphic_picture graphicRef57011" href="/z/d/graphic/57011.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ]. Residual neurologic deficits may also occur, manifested as recurrent seizures or motor deficits [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="local">
          'Lungs'
         </a>
         above and
         <a class="local">
          'Other sites'
         </a>
         above.)
        </p>
        <p>
         Early diagnosis is important to help prevent progression to fibrosis. As an example, in a retrospective study of 47 patients with chronic paracoccidioidomycosis who were treated with
         <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">
          itraconazole
         </a>
         and then followed for a median of 5.6 years, fibrosis correlated with the severity of the infiltrates at the time of diagnosis. Fibrosis was detected during the study in 83 percent of those with very severe infiltrates at diagnosis compared with 13 percent of patients with mild infiltrates [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         However, lung scarring can occur even in the setting of adequate antifungal therapy. In a study that evaluated 50 patients with inactive disease (≥6 months of treatment, negative mycology, resolution of skin and mucous lesions, low antibody titers), radiologic abnormalities were present on high resolution chest CT scans in 98 percent of cases [
         <a href="#rid33">
          33
         </a>
         ]. Findings included architectural distortion (90 percent), reticulate and septal thickening (88 percent), and centrilobular and paraseptal emphysema (84 percent). Pulmonary function and aerobic capacity were impaired in the majority of patients.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with chronic paracoccidioidomycosis with lung involvement, there is a broad differential diagnosis, which includes infectious causes such as tuberculosis, fungal infections (especially histoplasmosis), and noninfectious causes such as carcinoma, sarcoidosis, and idiopathic pulmonary fibrosis [
         <a href="#rid6">
          6,34
         </a>
         ]. Upper respiratory tract involvement may be suggestive of carcinoma. Mucosal and skin findings may be similar to those of leishmaniasis.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of paracoccidioidomycosis is based upon the microscopic visualization of fungal elements suggestive of
         <em>
          Paracoccidioides
         </em>
         spp and/or by culturing this fungus from clinical specimens. Serologic testing can be useful both for diagnosis and for monitoring the response to therapy [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Microscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The yeast form of
         <em>
          Paracoccidioides
         </em>
         spp can be visualized in sputum, abscess fluid, lymph node aspirates, scrapings of skin lesions, and/or biopsy samples of affected organs [
         <a href="#rid4">
          4
         </a>
         ]. Routine methods for wet mount preparation include potassium hydroxide (KOH) and calcofluor. Direct microscopy using KOH yields a diagnosis in over 90 percent of cases [
         <a href="#rid4">
          4
         </a>
         ]. A positive direct exam in the proper host is highly suggestive of the diagnosis, even if culture is negative. (See
         <a class="medical medical_review" href="/z/d/html/2434.html" rel="external">
          "Mycology and epidemiology of paracoccidioidomycosis", section on 'Mycology'
         </a>
         .)
        </p>
        <p>
         When demonstrated in clinical samples,
         <em>
          Paracoccidioides
         </em>
         spp are characterized as large (4 to 40 microns) round or oval "mother" yeast cell surrounded by multiple, attached, narrow-necked budding daughter yeast cells (resembling a "pilot's wheel") or mother yeast cell possessing only two attached daughter buds (resembling a "Mickey mouse head") (
         <a class="graphic graphic_picture graphicRef74383" href="/z/d/graphic/74383.html" rel="external">
          picture 4
         </a>
         ). If the typical multiple budding cells are not found, differentiation from other fungi, such as
         <em>
          Blastomyces dermatitidis
         </em>
         , can be difficult.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Culture
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Paracoccidioides
         </em>
         spp can be cultured from sputum, biopsy samples, and/or abscess fluid using Sabouraud dextrose agar or yeast extract agar containing
         <a class="drug drug_general" data-topicid="9241" href="/z/d/drug information/9241.html" rel="external">
          chloramphenicol
         </a>
         and cycloheximide incubated at room temperature. The mold form of
         <em>
          Paracoccidioides
         </em>
         spp usually takes as long as 20 to 30 days to grow [
         <a href="#rid3">
          3
         </a>
         ]. Some authors have suggested that cultures for
         <em>
          Paracoccidioides
         </em>
         are positive in up to 80 percent of samples [
         <a href="#rid4">
          4
         </a>
         ]. However, in our experience, cultures are frequently negative for
         <em>
          Paracoccidioides
         </em>
         because most specimens are obtained from sites that are colonized by bacteria, which inhibit fungal growth in culture. Consequently, the final diagnosis for most patients relies on the identification of typical yeast cells in direct exam of body fluids or tissue biopsy.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Pathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Methenamine silver stain or periodic acid Schiff stain are used to identify fungal elements in tissue samples due to their higher sensitivity compared with the hematoxylin-eosin stain. The presence of the characteristic large round yeast cells with multiple narrow-necked budding yeasts establishes the diagnosis (
         <a class="graphic graphic_picture graphicRef74383" href="/z/d/graphic/74383.html" rel="external">
          picture 4
         </a>
         ). (See
         <a class="local">
          'Microscopy'
         </a>
         above.)
        </p>
        <p>
         Histopathologic findings include chronic granulomatous or mixed granulomatous and suppurative infiltrates with the presence of epithelioid histiocytes, macrophages, and multinucleated giant cells surrounding the yeast cells [
         <a href="#rid3">
          3,9
         </a>
         ]. Granulomas surrounding the yeast cells are typical in patients with paracoccidioidomycosis [
         <a href="#rid9">
          9
         </a>
         ] but may also occur in patients with other endemic fungal infections.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Serologic tests
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           P. brasiliensis
          </em>
         </strong>
         – Detection of specific antibodies is used for the initial evaluation of patients suspected to be infected by
         <em>
          P. brasiliensis
         </em>
         complex. Serologic tests can also be used to monitor the response to therapy; a good clinical response is often associated with a reduction in the titer of serum antibodies. (See
         <a class="medical medical_review" href="/z/d/html/2422.html" rel="external">
          "Treatment of paracoccidioidomycosis", section on 'Serologic testing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Various serologic tests are available, including quantitative immunodiffusion, complement fixation, enzyme-linked immunosorbent assay (ELISA), and counterimmunoelectrophoresis [
         <a href="#rid36">
          36
         </a>
         ]. However, the utility of some of these serologic tests, such as complement fixation and ELISA, is limited by antigenic cross-reactivity between
         <em>
          P. brasiliensis
         </em>
         and other fungi, especially
         <em>
          Histoplasma capsulatum
         </em>
         [
         <a href="#rid4">
          4,36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2451.html" rel="external">
          "Diagnosis and treatment of pulmonary histoplasmosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Quantitative immunodiffusion testing is the most widely available assay in endemic regions. When testing for
         <em>
          P. brasiliensis
         </em>
         infection, any positive result should be considered suggestive of disease [
         <a href="#rid37">
          37
         </a>
         ]. Immunodiffusion testing represents the most reliable method for serologic diagnosis due to its high sensitivity and specificity, and because it is simple to perform [
         <a href="#rid4">
          4
         </a>
         ]. As an example, in a study that used a seven-day exoantigen in the immunodiffusion assay, the sensitivity was 97 percent and the specificity was 100 percent [
         <a href="#rid38">
          38
         </a>
         ]. Another study, which evaluated the performance of a double immunodiffusion assay in 401 cases, reported the sensitivity and specificity as 90 percent and 100 percent, respectively [
         <a href="#rid39">
          39
         </a>
         ]. However, unpublished experience with a larger number of samples suggests lower sensitivity (70 to 90 percent) and specificity (&gt;90 percent). In addition, serologic testing has a lower sensitivity in immunocompromised patients, such as those with human immunodeficiency virus (HIV) infection, compared with immunocompetent individuals. (See
         <a class="local">
          'Immunocompromised hosts'
         </a>
         below.) [
         <a href="#rid40">
          40
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           P. lutzii
          </em>
         </strong>
         – Patients infected with
         <em>
          P. lutzii
         </em>
         may be negative for the immunodiffusion test that detects antibodies against the gp43 antigen [
         <a href="#rid41">
          41
         </a>
         ]. However, a test for
         <em>
          P. lutzii
         </em>
         infection using a cell-free antigen preparation has been developed. In a study evaluating sera from 17 patients who had a clinical diagnosis of paracoccidioidomycosis, but a negative serologic test using a traditional immunodiffusion assay, all patients were reactive for
         <em>
          P. lutzii
         </em>
         by immunodiffusion using cell free antigen enzyme-linked immunosorbent assay, and Western blot [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4234009265">
         <span class="h2">
          1,3-beta-D-glucan test
         </span>
         <span class="headingEndMark">
          —
         </span>
         1,3-beta-D-glucan, a cell wall component of many fungi, is detected by the beta-D-glucan (BDG) assay. Although we do not routinely order this test as part of the initial workup in a patient with suspected paracoccidioidomycosis, a positive test could be consistent with infection. In one report, the BDG test was evaluated in 29 patients with paracoccidioidomycosis and was positive in all 17 patients with acute and 11 of 12 patients with chronic paracoccidioidomycosis, with high BDG serum levels (mean value of 3860 pg/mL and 1208 pg/mL in the acute and chronic forms, respectively) [
         <a href="#rid40">
          40
         </a>
         ]. However, a clinical response to treatment was not associated with decrease in BDG serum levels. It must be remembered that the BDG test is not specific for any fungal species, and the specificity of the assay can be decreased by multiple other clinical variables. More detailed information on this test is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15717.html" rel="external">
          "Diagnosis of invasive aspergillosis", section on 'Beta-D-glucan assay'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1072706873">
         <span class="h2">
          Skin testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Skin testing for the paracoccidioidin antigen is not useful for diagnosis of active disease. The sensitivity of this test is limited in severely ill patients. By contrast, it may be positive in healthy individuals from endemic areas previously exposed to the fungus.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Experimental methods
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other diagnostic modalities are being developed, but are not yet commercially available.
        </p>
        <p>
         Tests that detect antigen have been developed. These tests detect specific glycoprotein antigens (gp43 and gp70) in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid using immunoenzymatic assays, and appear to have higher sensitivity and specificity compared with traditional antibody detection methods [
         <a href="#rid36">
          36,43,44
         </a>
         ]. In addition, antigen detection may be particularly useful in immunocompromised patients as serologic testing may be falsely negative [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="local">
          'Serologic tests'
         </a>
         above.)
        </p>
        <p>
         A latex test that detects both antibodies and the gp43 antigen of
         <em>
          P. brasiliensis
         </em>
         in sera, cerebrospinal fluid, and bronchoalveolar lavage has also been developed. The sensitivity and specificity for detecting antibodies was 98 and 94 percent, and for detecting antigen was 97 and 89 percent, respectively [
         <a href="#rid45">
          45
         </a>
         ]. As with the other antigen tests, this assay is not available for use in clinical settings.
        </p>
        <p>
         Polymerase chain reaction (PCR)-based deoxyribonucleic acid (DNA) amplification methods have high sensitivity and specificity and may be used to identify the pathogen in biologic materials and cultures, but are not widely available [
         <a href="#rid46">
          46-48
         </a>
         ]. PCR can differentiate between
         <em>
          P. brasiliensis
         </em>
         and
         <em>
          P. lutzii
         </em>
         by sequencing the isolates, or using matrix-assisted laser desorption ionization-time of flight mass spectrometry [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of paracoccidioidomycosis is sought in patients who present with suggestive epidemiological and clinical findings. A typical example would be a man between 30 and 60 years of age who is an agricultural worker in an endemic region and who presents with any of the following findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic lung infiltrates (fibrosis, alveolar and/or interstitial infiltrates, cavities) with or without symptoms (cough, dyspnea)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic mucosal ulcers in the upper airways
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sialorrhea, odynophagia, hoarseness
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic skin lesions (nodules, ulcers) around natural orifices or on the lower limbs
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asymmetric lymph node enlargement (especially in the cervical region) with or without fistula formation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pseudotumoral brain lesions (see
         <a class="local">
          'Clinical manifestations'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Approach to diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial evaluation of patients with suspected chronic paracoccidioidomycosis should include all of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Imaging of affected areas (eg, chest radiograph and computed tomography [CT], brain CT or magnetic resonance imaging [MRI]). Since most patients have chronic pulmonary involvement, multiple lesions, and fibrosis, CT scanning is required to optimally characterize the lung lesions. A baseline chest radiograph is also useful since this modality can be used to follow response to therapy. If signs or symptoms of CNS involvement are present, a brain CT or MRI should be performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Direct examination and culture of sputum and/or biopsy specimens, depending upon sites of involvement
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serologic testing (preferably by quantitative immunodiffusion or counterimmunoelectrophoresis)
        </p>
        <p>
        </p>
        <p>
         Although the diagnosis is often established by direct examination and culture, serologic testing is important in order to have a baseline result for comparison during therapy since a reduction in antibody titers is expected during treatment (see
         <a class="medical medical_review" href="/z/d/html/2422.html" rel="external">
          "Treatment of paracoccidioidomycosis", section on 'Serologic testing'
         </a>
         ). A positive serologic test is also useful in cases in which direct microscopy and culture do not yield a positive result.
        </p>
        <p>
         During the initial evaluation of patients with chronic paracoccidioidomycosis, special attention should be devoted to the lungs (radiographic studies, pulmonary function tests), larynx, oral cavity, adrenal glands, and central nervous system. Abdominal and central nervous system CT scans should be requested only for patients with signs and symptoms suggestive of specific organ involvement.
        </p>
        <p>
         Considering the high frequency of adrenal dysfunction in patients with paracoccidioidomycosis, all patients (regardless of symptoms) should undergo adrenal evaluation at presentation. This includes an early morning serum cortisol level and evaluation of cortisol production in response to exogenous ACTH administration. Patients with clinical suspicion of Addison's disease require a complete investigation of adrenal function. (See
         <a class="medical medical_review" href="/z/d/html/154.html" rel="external">
          "Determining the etiology of adrenal insufficiency in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/157.html" rel="external">
          "Diagnosis of adrenal insufficiency in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Disseminated
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of chronic paracoccidioidomycosis causing disseminated disease is usually made by the detection of characteristic budding yeasts in a tissue biopsy, respiratory specimens (eg, sputum, bronchoalveolar lavage), or scrapings of skin or mucosal lesions. Direct examination and cultures of sputum are also useful in detecting fungal elements suggestive of
         <em>
          P. brasiliensis
         </em>
         . In these patients, the sensitivity of serology is very high and antibody titers by immunodiffusion usually range between 1:8 and 1:64. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Unifocal
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis may be challenging in situations in which the disease is restricted to a single organ, especially if the infection is in the central nervous system. In such cases, sensitivity of serology is low, tissue is difficult to obtain, and cultures are frequently negative. The detection of specific antigens (gp48 and gp70) either in the blood or cerebrospinal fluid using an immunoenzymatic assay may be helpful [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="local">
          'Experimental methods'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          IMMUNOCOMPROMISED HOSTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         While paracoccidioidomycosis is typically a disease affecting nonimmunocompromised individuals from endemic regions, it has been reported in immunocompromised individuals such as people with HIV [
         <a href="#rid50">
          50-52
         </a>
         ], patients with cancer [
         <a href="#rid53">
          53
         </a>
         ], solid organ transplant recipients [
         <a href="#rid54">
          54,55
         </a>
         ], and patients receiving tumor necrosis factor inhibitors [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         In individuals with HIV, paracoccidioidomycosis usually presents as disseminated disease, characterized by more exuberant and widespread findings than those observed in immunocompetent patients with the chronic form [
         <a href="#rid3">
          3,50,52,57,58
         </a>
         ]. In addition, mortality rates are usually higher in coinfected patients [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         In a retrospective study that included 53 patients with HIV and 106 patients without HIV, HIV-infected patients had more rapid progression of disease and were significantly more likely to have fever (96 versus 51 percent), lymphadenopathy (80 versus 62 percent), hepatomegaly (64 versus 20 percent), and skin lesions (67 versus 46 percent) but were less likely to have ulceration of the oral or nasal mucosa (21 versus 51 percent) compared with non–HIV-infected patients [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Eighty-five percent of HIV-infected individuals had pulmonary involvement compared with 69 percent of non–HIV-infected individuals, a difference which did not reach statistical significance. HIV-infected patients were significantly less likely to have a positive serologic test (76 versus 96 percent). HIV-infected individuals were significantly more likely to have suffered relapse by 24 months (19 versus 3 percent). The majority of HIV-infected patients (84 percent) had a CD4 cell count ≤200 cells/microL.
        </p>
        <p>
         This study suggests that paracoccidioidomycosis in HIV-infected patients has different clinical characteristics than the chronic form typically seen in immunocompetent adults. It is surprising that paracoccidioidomycosis does not occur more frequently in HIV-infected patients who live in endemic regions; in such patients, histoplasmosis and cryptococcosis occur more commonly than paracoccidioidomycosis despite a higher incidence of the latter disease in immunocompetent individuals [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Introduction
         </strong>
         − Paracoccidioidomycosis is a systemic endemic mycotic disease caused by the thermally dimorphic fungi of the genus
         <em>
          Paracoccidioides
         </em>
         , with two species:
         <em>
          Paracoccidioides brasiliensis
         </em>
         and
         <em>
          Paracoccidioides lutzii
         </em>
         . The disease has a geographic distribution limited to Central and South America. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Disease forms
         </strong>
         −
         <em>
          Paracoccidioides
         </em>
         spp typically causes asymptomatic pulmonary infection. However, if the infection is not contained by the host, the disease may evolve into one of two patterns: the chronic form, which represents reactivation of the primary infection, and the acute/subacute form. Over 80 to 90 percent of cases of paracoccidioidomycosis occur as the chronic form, which most commonly affects men who work in agriculture. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Signs and symptoms
         </strong>
         − The lungs and oral mucosa are the most frequently involved sites in chronic paracoccidioidomycosis. (See
         <a class="local">
          'Signs and symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Sequelae
         </strong>
         − An important aspect of chronic paracoccidioidomycosis is the development of sequelae, mostly represented by chronic respiratory failure, which results from fibrosis. Lung scarring occurs even in the setting of adequate antifungal therapy. Adrenal dysfunction is also frequently reported and mostly represented by asymptomatic limited reserve of adrenal function. (See
         <a class="local">
          'Sequelae'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         − In patients with chronic paracoccidioidomycosis with lung involvement, there is a broad differential diagnosis, which includes infectious causes such as tuberculosis, fungal infections (especially histoplasmosis), and noninfectious causes such as carcinoma, sarcoidosis, and idiopathic pulmonary fibrosis. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         − The diagnosis of paracoccidioidomycosis is based upon the microscopic visualization of fungal elements suggestive of
         <em>
          Paracoccidioides
         </em>
         spp and/or by culturing this fungus from clinical specimens. Serologic testing (preferably quantitative immunodiffusion) can be useful for both diagnosis and monitoring the response to therapy. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          When to suspect chronic paracoccidioidomycosis
         </strong>
         − Chronic paracoccidioidomycosis should be suspected in patients with chronic lung infiltrates (fibrosis, alveolar and/or interstitial infiltrates, cavities) with or without symptoms (cough, dyspnea); chronic mucosal ulcers in the upper airways; sialorrhea, odynophagia, or hoarseness; chronic skin lesions (nodules, ulcers); and/or asymmetric lymph node enlargement (especially in the cervical region). (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Approach to diagnosis
         </strong>
         − The initial evaluation of patients with suspected paracoccidioidomycosis should include imaging of affected areas (eg, chest computed tomography scan), direct examination and culture of sputum and/or biopsy specimens, and serologic testing. (See
         <a class="local">
          'Approach to diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunocompromised hosts
         </strong>
         − Paracoccidioidomycosis has been reported infrequently among patients with HIV or other causes of T cell–mediated immunodeficiency, such as cancer and solid organ transplantation. Patients with HIV usually present with disseminated disease and have high mortality rates. (See
         <a class="local">
          'Immunocompromised hosts'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Molina-Morant D, Sánchez-Montalvá A, Salvador F, et al. Imported endemic mycoses in Spain: Evolution of hospitalized cases, clinical characteristics and correlation with migratory movements, 1997-2014. PLoS Negl Trop Dis 2018; 12:e0006245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Queiroz-Telles FV, Peçanha Pietrobom PM, Rosa Júnior M, et al. New Insights on Pulmonary Paracoccidioidomycosis. Semin Respir Crit Care Med 2020; 41:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993; 6:89.
          </a>
         </li>
         <li class="breakAll">
          Restrepo A, Tobon AM, Agudelo CA. Paracoccidioidomycosis. In: Diagnosis and Treatment of Human Mycoses, 1st edition, Hospenthal, DR, Rinaldi, MG (Eds), Humana Press, Totowa, NJ 2008. p.331.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hahn RC, Rodrigues AM, Della Terra PP, et al. Clinical and epidemiological features of paracoccidioidomycosis due to Paracoccidioides lutzii. PLoS Negl Trop Dis 2019; 13:e0007437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Restrepo A, Benard G, de Castro CC, et al. Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med 2008; 29:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coutinho ZF, Wanke B, Travassos C, et al. Hospital morbidity due to paracoccidioidomycosis in Brazil (1998-2006). Trop Med Int Health 2015; 20:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peçanha PM, Batista Ferreira ME, Massaroni Peçanha MA, et al. Paracoccidioidomycosis: Epidemiological and Clinical Aspects in 546 Cases Studied in the State of Espírito Santo, Brazil. Am J Trop Med Hyg 2017; 97:836.
          </a>
         </li>
         <li class="breakAll">
          Restrepo A, Tobon AM. Paracoccidioides brasiliensis. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Elsevier, Philadelphia 2005. p.3062.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Correa AL, Franco L, Restrepo A . Paracoccidioidomicosis: Coexistencia de lesiones pulmonares y patologia pulmonar silente. Acta Med Colomb 1991; 16:304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tobón AM, Agudelo CA, Osorio ML, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis 2003; 37:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bicalho RN, Santo MF, de Aguiar MC, Santos VR. Oral paracoccidioidomycosis: a retrospective study of 62 Brazilian patients. Oral Dis 2001; 7:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silva CO, Almeida AS, Pereira AA, et al. Gingival involvement in oral paracoccidioidomycosis. J Periodontol 2007; 78:1229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Godoy H, Reichart PA. Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina. Mycoses 2003; 46:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sant'Anna GD, Mauri M, Arrarte JL, Camargo H Jr. Laryngeal manifestations of paracoccidioidomycosis (South American blastomycosis). Arch Otolaryngol Head Neck Surg 1999; 125:1375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramos-E-Silva M, Saraiva Ldo E. Paracoccidioidomycosis. Dermatol Clin 2008; 26:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamaga LY, Benard G, Hironaka FH, et al. The role of gallium-67 scan in defining the extent of disease in an endemic deep mycosis, paracoccidioidomycosis: a predominantly multifocal disease. Eur J Nucl Med Mol Imaging 2003; 30:888.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colombo AL, Faiçal S, Kater CE. Systematic evaluation of the adrenocortical function in patients with paracoccidioidomycosis. Mycopathologia 1994; 127:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paniago AM, de Oliveira PA, Aguiar ES, et al. Neuroparacoccidioidomycosis: analysis of 13 cases observed in an endemic area in Brazil. Trans R Soc Trop Med Hyg 2007; 101:414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oñate JM, Tobón AM, Restrepo A. [Adrenal gland insufficiency secondary to paracoccidioidomycosis]. Biomedica 2002; 22:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kauffman CA. Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis. J Fungi (Basel) 2019; 5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Macedo PM, Falcão EMM, Freitas DFS, et al. Neuroparacoccidioidomycosis: A 13-Year Cohort Study, Rio de Janeiro, Brazil. J Fungi (Basel) 2020; 6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amstalden EM, Xavier R, Kattapuram SV, et al. Paracoccidioidomycosis of bones and joints. A clinical, radiologic, and pathologic study of 9 cases. Medicine (Baltimore) 1996; 75:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doria AS, Taylor GA. Bony involvement in paracoccidioidomycosis. Pediatr Radiol 1997; 27:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Severo LC, Kauer CL, Oliveira Fd, et al. Paracoccidioidomycosis of the male genital tract. Report of eleven cases and a review of Brazilian literature. Rev Inst Med Trop Sao Paulo 2000; 42:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cruz AA, Zenha F, Silva JT Jr, Martinez R. Eyelid involvement in paracoccidioidomycosis. Ophthal Plast Reconstr Surg 2004; 20:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dantas AM, Yamane R, Camara AG. South American blastomycosis: ophthalmic and oculomotor nerve lesions. Am J Trop Med Hyg 1990; 43:386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           do Valle AC, Guimarães RR, Lopes DJ, Capone D. [Thoracic radiologic aspects in paracoccidioidomycosis]. Rev Inst Med Trop Sao Paulo 1992; 34:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barreto MM, Marchiori E, Amorim VB, et al. Thoracic paracoccidioidomycosis: radiographic and CT findings. Radiographics 2012; 32:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosa Júnior M, Amorim AC, Baldon IV, et al. Paracoccidioidomycosis of the Central Nervous System: CT and MR Imaging Findings. AJNR Am J Neuroradiol 2019; 40:1681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosa Júnior M, Baldon IV, Amorim AFC, et al. Imaging paracoccidioidomycosis: A pictorial review from head to toe. Eur J Radiol 2018; 103:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francesconi F, da Silva MT, Costa RL, et al. Long-term outcome of neuroparacoccidioidomycosis treatment. Rev Soc Bras Med Trop 2011; 44:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costa AN, Benard G, Albuquerque AL, et al. The lung in paracoccidioidomycosis: new insights into old problems. Clinics (Sao Paulo) 2013; 68:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blotta MH, Mamoni RL, Oliveira SJ, et al. Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg 1999; 61:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikanai-Yasuda MA, Mendes RP, Colombo AL, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop 2017; 50:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Camargo ZP. Serology of paracoccidioidomycosis. Mycopathologia 2008; 165:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travassos LR, Taborda CP, Colombo AL. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther 2008; 6:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Camargo Z, Unterkircher C, Campoy SP, Travassos LR. Production of Paracoccidioides brasiliensis exoantigens for immunodiffusion tests. J Clin Microbiol 1988; 26:2147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moreto TC, Marques ME, de Oliveira ML, et al. Accuracy of routine diagnostic tests used in paracoccidioidomycosis patients at a university hospital. Trans R Soc Trop Med Hyg 2011; 105:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melo ASA, Santos DWCL, Lima SL, et al. Evaluation of (1 → 3)-β-D-glucan assay for diagnosing paracoccidioidomycosis. Mycoses 2020; 63:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batista J Jr, de Camargo ZP, Fernandes GF, et al. Is the geographical origin of a Paracoccidioides brasiliensis isolate important for antigen production for regional diagnosis of paracoccidioidomycosis? Mycoses 2010; 53:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gegembauer G, Araujo LM, Pereira EF, et al. Serology of paracoccidioidomycosis due to Paracoccidioides lutzii. PLoS Negl Trop Dis 2014; 8:e2986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marques da Silva SH, Colombo AL, Blotta MH, et al. Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis. J Clin Microbiol 2003; 41:3675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marques da Silva SH, Queiroz-Telles F, Colombo AL, et al. Monitoring gp43 antigenemia in Paracoccidioidomycosis patients during therapy. J Clin Microbiol 2004; 42:2419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dos Santos PO, Rodrigues AM, Fernandes GF, et al. Immunodiagnosis of paracoccidioidomycosis due to Paracoccidioides brasiliensis using a latex test: detection of specific antibody anti-gp43 and specific antigen gp43. PLoS Negl Trop Dis 2015; 9:e0003516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motoyama AB, Venancio EJ, Brandão GO, et al. Molecular identification of Paracoccidioides brasiliensis by PCR amplification of ribosomal DNA. J Clin Microbiol 2000; 38:3106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gomes GM, Cisalpino PS, Taborda CP, de Camargo ZP. PCR for diagnosis of paracoccidioidomycosis. J Clin Microbiol 2000; 38:3478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaviria M, Rivera V, Muñoz-Cadavid C, et al. Validation and clinical application of a nested PCR for paracoccidioidomycosis diagnosis in clinical samples from Colombian patients. Braz J Infect Dis 2015; 19:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nobrega de Almeida J Jr, Del Negro GM, Grenfell RC, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for differentiation of the dimorphic fungal species Paracoccidioides brasiliensis and Paracoccidioides lutzii. J Clin Microbiol 2015; 53:1383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silva-Vergara ML, Teixeira AC, Curi VG, et al. Paracoccidioidomycosis associated with human immunodeficiency virus infection. Report of 10 cases. Med Mycol 2003; 41:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paniago AM, de Freitas AC, Aguiar ES, et al. Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect 2005; 51:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morejón KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg 2009; 80:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikanai-Yasuda MA, Conceição YM, Kono A, et al. Neoplasia and paracoccidioidomycosis. Mycopathologia 2008; 165:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zavascki AP, Bienardt JC, Severo LC. Paracoccidioidomycosis in organ transplant recipient: case report. Rev Inst Med Trop Sao Paulo 2004; 46:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikanai-Yasuda MA, Duarte MI, Nunes DF, et al. Paracoccidioidomycosis in a renal transplant recipient. J Med Vet Mycol 1995; 33:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Covre LCP, Hombre PM, Falqueto A, et al. Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy. Rev Soc Bras Med Trop 2018; 51:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Almeida FA, Neves FF, Mora DJ, et al. Paracoccidioidomycosis in Brazilian Patients With and Without Human Immunodeficiency Virus Infection. Am J Trop Med Hyg 2017; 96:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Almeida JN Jr, Peçanha-Pietrobom PM, Colombo AL. Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review. J Fungi (Basel) 2018; 5.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2435 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29447170" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Imported endemic mycoses in Spain: Evolution of hospitalized cases, clinical characteristics and correlation with migratory movements, 1997-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32000284" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : New Insights on Pulmonary Paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8472249" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Paracoccidioidomycosis: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8472249" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Paracoccidioidomycosis: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31163028" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Clinical and epidemiological features of paracoccidioidomycosis due to Paracoccidioides lutzii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18366000" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Pulmonary paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25645820" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hospital morbidity due to paracoccidioidomycosis in Brazil (1998-2006).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28749757" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Paracoccidioidomycosis: Epidemiological and Clinical Aspects in 546 Cases Studied in the State of Espírito Santo, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28749757" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Paracoccidioidomycosis: Epidemiological and Clinical Aspects in 546 Cases Studied in the State of Espírito Santo, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Paracoccidioidomicosis: Coexistencia de lesiones pulmonares y patologia pulmonar silente
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13130400" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11354923" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Oral paracoccidioidomycosis: a retrospective study of 62 Brazilian patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17608577" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Gingival involvement in oral paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14622391" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10604418" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Laryngeal manifestations of paracoccidioidomycosis (South American blastomycosis).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18346557" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12709832" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The role of gallium-67 scan in defining the extent of disease in an endemic deep mycosis, paracoccidioidomycosis: a predominantly multifocal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7984218" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Systematic evaluation of the adrenocortical function in patients with paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17011605" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Neuroparacoccidioidomycosis: analysis of 13 cases observed in an endemic area in Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12404928" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : [Adrenal gland insufficiency secondary to paracoccidioidomycosis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31323746" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33233507" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Neuroparacoccidioidomycosis: A 13-Year Cohort Study, Rio de Janeiro, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8699961" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Paracoccidioidomycosis of bones and joints. A clinical, radiologic, and pathologic study of 9 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8995173" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Bony involvement in paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10742725" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Paracoccidioidomycosis of the male genital tract. Report of eleven cases and a review of Brazilian literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15167729" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Eyelid involvement in paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2240366" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : South American blastomycosis: ophthalmic and oculomotor nerve lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1340023" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : [Thoracic radiologic aspects in paracoccidioidomycosis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22236894" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Thoracic paracoccidioidomycosis: radiographic and CT findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31515216" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Paracoccidioidomycosis of the Central Nervous System: CT and MR Imaging Findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29685479" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Imaging paracoccidioidomycosis: A pictorial review from head to toe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21340402" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Long-term outcome of neuroparacoccidioidomycosis treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23778339" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The lung in paracoccidioidomycosis: new insights into old problems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10497977" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28746570" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Brazilian guidelines for the clinical management of paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18777635" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Serology of paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18380607" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Treatment options for paracoccidioidomycosis and new strategies investigated.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3141460" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Production of Paracoccidioides brasiliensis exoantigens for immunodiffusion tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21684567" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Accuracy of routine diagnostic tests used in paracoccidioidomycosis patients at a university hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31532045" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Evaluation of (1 → 3)-β-D-glucan assay for diagnosing paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19422525" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Is the geographical origin of a Paracoccidioides brasiliensis isolate important for antigen production for regional diagnosis of paracoccidioidomycosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25032829" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Serology of paracoccidioidomycosis due to Paracoccidioides lutzii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12904374" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15184413" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Monitoring gp43 antigenemia in Paracoccidioidomycosis patients during therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25679976" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Immunodiagnosis of paracoccidioidomycosis due to Paracoccidioides brasiliensis using a latex test: detection of specific antibody anti-gp43 and specific antigen gp43.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10921990" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Molecular identification of Paracoccidioides brasiliensis by PCR amplification of ribosomal DNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10970409" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : PCR for diagnosis of paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26100437" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Validation and clinical application of a nested PCR for paracoccidioidomycosis diagnosis in clinical samples from Colombian patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25631803" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Matrix-assisted laser desorption ionization-time of flight mass spectrometry for differentiation of the dimorphic fungal species Paracoccidioides brasiliensis and Paracoccidioides lutzii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12964719" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Paracoccidioidomycosis associated with human immunodeficiency virus infection. Report of 10 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16230222" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19270282" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18780466" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Neoplasia and paracoccidioidomycosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15517034" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Paracoccidioidomycosis in organ transplant recipient: case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8683410" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Paracoccidioidomycosis in a renal transplant recipient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29768566" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pulmonary paracoccidioidomycosis: a case report of reactivation in a patient receiving biological therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27895278" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Paracoccidioidomycosis in Brazilian Patients With and Without Human Immunodeficiency Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30587784" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
